Park Ha Biological Technology Co., Ltd. (PHH) - Total Assets

Latest as of June 2025: $5.83 Million USD

Based on the latest financial reports, Park Ha Biological Technology Co., Ltd. (PHH) holds total assets worth $5.83 Million USD as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Park Ha Biological Technology Co., Ltd. - Total Assets Trend (1993–2024)

This chart illustrates how Park Ha Biological Technology Co., Ltd.'s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Park Ha Biological Technology Co., Ltd. - Asset Composition Analysis

Current Asset Composition (December 2024)

Park Ha Biological Technology Co., Ltd.'s total assets of $5.83 Million consist of 92.3% current assets and 7.8% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 17.8%
Accounts Receivable $1.11 Million 36.0%
Inventory $71.49K 2.3%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $7.62K 0.3%
Goodwill $0.00 0.0%

Asset Composition Trend (1993–2024)

This chart illustrates how Park Ha Biological Technology Co., Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Park Ha Biological Technology Co., Ltd.'s current assets represent 92.3% of total assets in 2024, an increase from 9.9% in 1993.
  • Cash Position: Cash and equivalents constituted 17.8% of total assets in 2024, up from 0.0% in 1993.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 1.0% in 1993.
  • Asset Diversification: The largest asset category is accounts receivable at 36.0% of total assets.

Park Ha Biological Technology Co., Ltd. Competitors by Total Assets

Key competitors of Park Ha Biological Technology Co., Ltd. based on total assets are shown below.

Park Ha Biological Technology Co., Ltd. - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 3.68 1.71 2.46
Quick Ratio 3.63 1.62 0.75
Cash Ratio 0.00 0.00 0.00
Working Capital $4.07 Million $758.54K $829.00 Million

Park Ha Biological Technology Co., Ltd. - Advanced Valuation Insights

This section examines the relationship between Park Ha Biological Technology Co., Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.17
Latest Market Cap to Assets Ratio 4.23
Asset Growth Rate (YoY) 36.1%
Total Assets $3.08 Million
Market Capitalization $13.04 Million USD

Valuation Analysis

Premium Asset Valuation: The market values Park Ha Biological Technology Co., Ltd.'s assets at a significant premium (4.23x), suggesting investors see substantial growth potential or unique competitive advantages.

Rapid Asset Growth: Park Ha Biological Technology Co., Ltd.'s assets grew by 36.1% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Park Ha Biological Technology Co., Ltd. (1993–2024)

The table below shows the annual total assets of Park Ha Biological Technology Co., Ltd. from 1993 to 2024.

Year Total Assets Change
2024-12-31 $3.08 Million +36.14%
2023-12-31 $2.26 Million -10.08%
2022-12-31 $2.52 Million +323.87%
2021-12-31 $594.22K -99.97%
2017-12-31 $1.81 Billion -42.96%
2016-12-31 $3.17 Billion -13.06%
2015-12-31 $3.65 Billion -14.99%
2014-12-31 $4.30 Billion -51.45%
2013-12-31 $8.85 Billion -7.86%
2012-12-31 $9.60 Billion -1.78%
2011-12-31 $9.78 Billion -13.25%
2010-12-31 $11.27 Billion +38.74%
2009-12-31 $8.12 Billion -1.81%
2008-12-31 $8.27 Billion -11.58%
2007-12-31 $9.36 Billion -13.04%
2006-12-31 $10.76 Billion +7.98%
2005-12-31 $9.96 Billion -13.48%
2004-12-31 $11.52 Billion +0.10%
2003-12-31 $11.51 Billion +14.16%
2002-12-31 $10.08 Billion +5.08%
2001-12-31 $9.59 Billion +117.16%
2000-12-31 $4.42 Billion +3.03%
1999-12-31 $4.29 Billion -52.54%
1998-12-31 $9.03 Billion +20.99%
1997-12-31 $7.47 Billion +31.61%
1995-12-31 $5.67 Billion +12.57%
1994-12-31 $5.04 Billion +5.72%
1993-12-31 $4.77 Billion --

About Park Ha Biological Technology Co., Ltd.

NASDAQ:PHH USA Household & Personal Products
Market Cap
$13.04 Million
Market Cap Rank
#31099 Global
#9561 in USA
Share Price
$0.39
Change (1 day)
-0.08%
52-Week Range
$0.37 - $41.01
All Time High
$41.01
About

Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells produ… Read more